| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.07 |